• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度北部农村三级保健中心就诊的甲状腺功能减退症患者的非酒精性脂肪性肝病。

Non-alcoholic fatty liver disease in patients with hypothyroidism presenting at a rural tertiary care centre in north India.

机构信息

Senior Resident, Department of Medicine, Dayanand Medical College, Ludhiana, India.

Professor, Department of Medicine, Maharishi Markandeshwar Institute of Medical Sciences & Research, Mullana, Ambala, India.

出版信息

Trop Doct. 2021 Apr;51(2):181-184. doi: 10.1177/0049475520945058. Epub 2020 Aug 9.

DOI:10.1177/0049475520945058
PMID:32772844
Abstract

Apart from its association with metabolic syndrome and diabetes mellitus, non-alcoholic fatty liver disease (NAFLD) has been thought to be linked with other endocrine and metabolic disorders. Recent data suggest that hypothyroidism may be a significant risk factor for development and progression of NAFLD. The present study was conducted to evaluate the presence of NAFLD in patients with hypothyroidism presenting to a rural tertiary care centre in north India. The diagnosis of NAFLD was made on the basis of radiological findings and derangement of liver enzymes. Our findings showed that ultrasonographic evidence of fatty liver as well as increase in the serum transaminase level above normal range were significantly higher in hypothyroidism patients as compared with controls. On multivariate regression analysis of the patients' data, the presence of hypothyroidism was independently associated with risk of NAFLD. We therefore conclude that hypothyroidism is a significant independent risk factor.

摘要

除了与代谢综合征和糖尿病有关外,非酒精性脂肪肝(NAFLD)也被认为与其他内分泌和代谢紊乱有关。最近的数据表明,甲状腺功能减退症可能是 NAFLD 发生和进展的一个重要危险因素。本研究旨在评估在印度北部农村三级医疗中心就诊的甲状腺功能减退症患者中是否存在 NAFLD。NAFLD 的诊断基于影像学发现和肝脏酶的紊乱。我们的研究结果表明,与对照组相比,甲状腺功能减退症患者的超声检查有脂肪肝的证据,以及血清转氨酶水平升高超过正常范围,这两种情况的发生率明显更高。对患者数据的多变量回归分析表明,甲状腺功能减退症的存在与 NAFLD 的风险独立相关。因此,我们得出结论,甲状腺功能减退症是一个重要的独立危险因素。

相似文献

1
Non-alcoholic fatty liver disease in patients with hypothyroidism presenting at a rural tertiary care centre in north India.印度北部农村三级保健中心就诊的甲状腺功能减退症患者的非酒精性脂肪性肝病。
Trop Doct. 2021 Apr;51(2):181-184. doi: 10.1177/0049475520945058. Epub 2020 Aug 9.
2
Prevalence of hypothyroidism in nonalcoholic fatty liver disease in patients attending a tertiary hospital in western India.印度西部一家三级医院非酒精性脂肪性肝病患者甲状腺功能减退症的患病率
Indian J Gastroenterol. 2015 Mar;34(2):169-73. doi: 10.1007/s12664-015-0541-z. Epub 2015 Apr 16.
3
Relationship between hypothyroidism and non-alcoholic fatty liver disease in the Spanish population.西班牙人群中甲状腺功能减退症与非酒精性脂肪性肝病之间的关系。
Med Clin (Barc). 2020 Jan 10;154(1):1-6. doi: 10.1016/j.medcli.2019.03.018. Epub 2019 May 29.
4
Non-alcoholic fatty liver disease across the spectrum of hypothyroidism.非酒精性脂肪性肝病与甲状腺功能减退症的关系。
J Hepatol. 2012 Jul;57(1):150-6. doi: 10.1016/j.jhep.2012.02.027. Epub 2012 Mar 14.
5
Impact of thyroid disorders on the incidence of non-alcoholic fatty liver disease in Germany.甲状腺疾病对德国非酒精性脂肪性肝病发病率的影响。
United European Gastroenterol J. 2021 Sep;9(7):829-836. doi: 10.1002/ueg2.12124. Epub 2021 Jul 20.
6
To Assess Non Alcoholic Fatty Liver Disease in Patients with Clinical and Subclinical Hypothyroidism.评估临床和亚临床甲状腺功能减退患者的非酒精性脂肪性肝病
J Assoc Physicians India. 2023 Jan;71(1):1.
7
Non-alcoholic fatty liver disease prevalence and associated risk factors--A study from rural sector of Maharashtra.非酒精性脂肪性肝病的患病率及相关危险因素——一项来自马哈拉施特拉邦农村地区的研究
Trop Gastroenterol. 2015 Jan-Mar;36(1):25-30. doi: 10.7869/tg.241.
8
Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years.亚临床和临床甲状腺功能减退症与非酒精性脂肪性肝病:一项针对18至65岁随机人群样本的横断面研究。
BMC Endocr Disord. 2015 Aug 15;15:41. doi: 10.1186/s12902-015-0030-5.
9
Male-specific association between subclinical hypothyroidism and the risk of non-alcoholic fatty liver disease estimated by hepatic steatosis index: Korea National Health and Nutrition Examination Survey 2013 to 2015.亚临床甲状腺功能减退症与肝脂肪变性指数评估的非酒精性脂肪性肝病风险的男性相关性:韩国 2013-2015 年国家健康和营养检查调查。
Sci Rep. 2018 Oct 11;8(1):15145. doi: 10.1038/s41598-018-32245-0.
10
Non-alcoholic Fatty Liver Disease in Overt Hypothyroidism: A Cross-Sectional Study in a Tertiary Care Hospital.显性甲状腺功能减退症中的非酒精性脂肪性肝病:一项三级医院的横断面研究。
Cureus. 2023 Apr 4;15(4):e37094. doi: 10.7759/cureus.37094. eCollection 2023 Apr.

引用本文的文献

1
Evidence on the link between hypothyroidism and non-alcoholic fatty liver disease: an updated systematic review.甲状腺功能减退与非酒精性脂肪性肝病之间关联的证据:一项更新的系统评价。
BMC Endocr Disord. 2025 Jul 1;25(1):154. doi: 10.1186/s12902-025-01977-2.
2
Management of metabolic dysfunction-associated steatotic liver disease (MASLD)-An expert consensus statement from Indian diabetologists' perspective.代谢功能障碍相关脂肪性肝病(MASLD)的管理——来自印度糖尿病专家视角的专家共识声明
Diabetes Obes Metab. 2025 Jun;27 Suppl 4(Suppl 4):3-20. doi: 10.1111/dom.16496. Epub 2025 Jun 2.
3
Vitamin E Prevented Hepatic and Renal Tissue Damage in Hypothyroid Rats.
维生素E预防甲状腺功能减退大鼠的肝脏和肾脏组织损伤。
Adv Biomed Res. 2023 Mar 28;12:75. doi: 10.4103/abr.abr_275_21. eCollection 2023.
4
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD).印度国家肝脏研究协会(INASL)关于非酒精性脂肪性肝病(NAFLD)命名、诊断和治疗的指导文件。
J Clin Exp Hepatol. 2023 Mar-Apr;13(2):273-302. doi: 10.1016/j.jceh.2022.11.014. Epub 2022 Dec 7.
5
Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis.印度非酒精性脂肪性肝病的患病率:一项系统评价与荟萃分析。
J Clin Exp Hepatol. 2022 May-Jun;12(3):818-829. doi: 10.1016/j.jceh.2021.11.010. Epub 2021 Nov 25.
6
TSH Levels as an Independent Risk Factor for NAFLD and Liver Fibrosis in the General Population.促甲状腺激素水平作为普通人群中非酒精性脂肪性肝病和肝纤维化的独立危险因素
J Clin Med. 2021 Jun 29;10(13):2907. doi: 10.3390/jcm10132907.